Solicitation 2024 Annoucement - POCTRN

Center news

null Solicitation 2024 Annoucement

POCTRN Unveils Six New Funding Opportunities to Propel Point-of-Care Technologies

In a stride towards fostering groundbreaking advancements in healthcare technology, the National Institute of Biomedical Imaging and Bioengineering's Point-of-Care Technologies Research Network (NIBIB's POCTRN) program announces six exciting new funding opportunities. 

POCTRN is actively seeking applications from both academic and industry innovators who are spearheading transformative developments in point-of-care technologies. This call for applications encompasses a diverse range of areas, including but not limited to sexually transmitted infections (STIs), cancer detection, emerging infectious diseases in low-resource settings, and addressing challenges related to heart, lung, blood, and sleep disorders. 

Each center offers unique awards, with the potential for funding reaching up to $150,000. Successful applicants may also receive 12 months of in-kind support services. 

To learn more about this opportunity and understand the application process, visit our website. 

Expressions of interest are due at 11:59 PM on March 31, 2024. 

Apply today and join us in revolutionizing the landscape of point-of-care technologies. 

Learn More or Apply

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

ABOUT RADx

In the News 

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests

NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests

The need for new test verification and regulatory support for innovative diagnostics

NIH-funded screening study builds case for frequent COVID-19 antigen testing

RADx partnerships speed new COVID testing

One Year of RADx Tech Success

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort 

Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology

Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative

NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration

The National Strategy From the COVID-19 Response and Pandemic Preparedness

Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced

The Need for More and Better Testing for COVID-19